BRINGING DRUGS TO EVERY TARGET
Scaling AI to become more data efficient and find drugs for otherwise intractable targets
Uncovering the 80% dark matter
We believe that the world is missing out on 80% of targets causing diseases restricted by lack of data
By making our computational methods more data efficient, we can change the face of medicine discovery.
Our transformative platform RosalindAI: Everything drug hunters need to advance drug discovery
We partner with drug hunters in pharmaceutical, biotech and research organisations and develop AI to help our partners overcome the challenges of drug discovery. RosalindAI is the first end-to-end AI platform for drug discovery R&D empowering drug hunters with cutting-edge AI technologies to bring drugs to every target.
LARGE SCALE IMPACT
We can algorithmically predict more than 50 ADMET and Physiochemical properties
Our models are trained on a repository of data that is 10x larger than what is available in the public domain
Our highly scalable and parallelised cloud infrastructure allows us to use AI to virtually screen one Billion compounds in 24 hours
BENEFITS AND OUTCOMES
Our AI models achieve
Our AI models are up to 8% more accurate over current AI approaches
We use our methods to intelligently select training data leading to almost 50% reduction in lab experiments
Our novel in silico drug design can almost triple the number of targets tractable by AI
We are a team of scientists, drug hunters and engineers passionate about funding treatment for devastating diseases. We came together to help accelerate drug discovery and driver on our mission to bring drugs to every target.
We believe that scaling AI to become more data efficient has a transformative impact on drug discovery. We also believe that the power of AI should be at the fingertips of every drug hunter. We have a strategic focus on being the AI partner of choice to help progress pharmaceuticals, biotechs and researchers around the world.